[1] Selkoe D J. The cell biology of β-amyloid precursor protein, presenilin in Alzheimer's disease [J]. Trends Cell Biol, 1998, 8: 447-453.
[2] Wang R, Sweeney D, Gandy S E, et al. The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitationmass spectrometry [J]. J Biol Chem, 1996, 271: 31 894-31 902.
[3] Hardy J A, Higgins G A. Alzheimer’s disease: the amyloid cascade hypothesis [J]. Science, 1992, 256: 184-185.
[4] Hardy J, Selkoe D J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics [J]. Science, 2002, 297: 353-356.
[5] Danielsson J,Jarvet J,Damberg P,et al. Two-Site binding of β-Cyclodextrin to the Alzheimer Aβ(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts [J]. Biochemistry, 2004, 43(20): 6 261-6 269.
[6] Wishart D S, Bigam C G, Yao J, et al. 1H, 13C and 15N chemical shift referencing in biomolecular NMR [J]. J Biomol NMR, 1995, 6: 135-140.
[7] Delaglio F, Grzesiek S, Vuister G W, et al. A multidimensional spectral processing system based on UNIX pipes [J]. J Biomol NMR, 1995, 6: 277-293.
[8] Goddard T D, Kneller D G. SPARKY 3. San Francisco: University of California.
[9] Wüthrich K. NMR of Proteins and Nucleic Acid [M]. USA: Wiely & New York, 1986.
|